Literature DB >> 32883103

Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights From the Cardiac Care Outcomes Assessment Program (COAP) in Washington State.

Ashwin S Nathan1,2,3, Swathi Raman4, Nancy Yang4, Ian Painter5, Sameed Ahmed M Khatana1,2,3, Elias J Dayoub2,3,6, Howard C Herrmann1, Robert W Yeh7, Peter W Groeneveld2,3,8,6, Jacob A Doll5, James M McCabe5,9, Ravi S Hira5,9, Jay Giri1,2,3,6, Alexander C Fanaroff1,2,3.   

Abstract

BACKGROUND: For patients presenting with ST-segment-elevation myocardial infarction, national quality initiatives monitor hospitals' proportion of cases with door-to-balloon (D2B) time under 90 minutes. Hospitals are allowed to exclude patients from reporting and may modify behavior to improve performance. We sought to identify whether there is a discontinuity in the number of cases included in the D2B time metric at 90 minutes and whether operators were increasingly likely to pursue femoral access in patients with less time to meet the 90-minute quality metric.
METHODS: Adult patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention from 2011 to 2018 were identified from the Cardiac Care Outcomes Assessment Program, a quality improvement registry in Washington state. We used the regression discontinuity framework to test for discontinuity at 90 minutes among the included cases. We defined a novel variable, remaining D2B as 90 minutes minus the time between hospital arrival and catheterization laboratory arrival. We estimated multivariable logistic regression models to assess the relationship between remaining D2B time and access site.
RESULTS: A total of 19 348 patients underwent primary percutaneous coronary intervention and were included in the analysis. Overall, 7436 (38.4%) were excluded from the metric. There appeared to be a visual discontinuity in included cases around 90 minutes; however, local quadratic regression around the 90-minute cutoff did not reveal evidence of a significant discontinuity (P=0.66). Multivariable analysis showed no significant relationship between remaining D2B time and the odds of undergoing femoral access (P=0.73).
CONCLUSIONS: Among patients undergoing percutaneous coronary intervention for ST-segment-elevation myocardial infarction, we did not find evidence of a statistically significant discontinuity in the frequency of included cases around 90 minutes or an increased preference for femoral access correlated with decreasing time to meet the 90-minute D2B time quality metric. Together, these findings indicate no evidence of widespread inappropriate methods to improve performance on D2B time metrics.

Entities:  

Keywords:  association; catheterization; hospitals; myocardial infarction; percutaneous coronary intervention

Mesh:

Year:  2020        PMID: 32883103      PMCID: PMC9125502          DOI: 10.1161/CIRCINTERVENTIONS.120.009179

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  20 in total

1.  Door-to-balloon time and mortality among patients undergoing primary PCI.

Authors:  Daniel S Menees; Eric D Peterson; Yongfei Wang; Jeptha P Curtis; John C Messenger; John S Rumsfeld; Hitinder S Gurm
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

2.  Call-to-balloon time dashboard in patients with ST-segment elevation myocardial infarction results in significant improvement in the logistic chain.

Authors:  Maaike P J Hermans; Matthijs A Velders; Martin Smeekes; Olivier S Drexhage; Raymond W M Hautvast; Timon Ytsma; Martin J Schalij; Victor A W M Umans
Journal:  EuroIntervention       Date:  2017-08-04       Impact factor: 6.534

3.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  J Am Coll Cardiol       Date:  2012-12-17       Impact factor: 24.094

4.  Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator.

Authors:  James G Jollis; Hussein R Al-Khalidi; Mayme L Roettig; Peter B Berger; Claire C Corbett; Harold L Dauerman; Christopher B Fordyce; Kathleen Fox; J Lee Garvey; Tammy Gregory; Timothy D Henry; Ivan C Rokos; Matthew W Sherwood; Robert E Suter; B Hadley Wilson; Christopher B Granger
Journal:  Circulation       Date:  2016-08-02       Impact factor: 29.690

5.  Washington State's model of physician leadership in cardiac outcomes reporting.

Authors:  J R Goss; R W Whitten; R C Phillips; G G Johnston; B O Hofer; P B Mansfield; S L Tidwell; J A Spertus; J P LoGerfo
Journal:  Ann Thorac Surg       Date:  2000-09       Impact factor: 4.330

6.  Frequency of nonsystem delays in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and implications for door-to-balloon time reporting (from the American Heart Association Mission: Lifeline program).

Authors:  David A Cotoni; Matthew T Roe; Shuang Li; Michael C Kontos
Journal:  Am J Cardiol       Date:  2014-04-16       Impact factor: 2.778

7.  Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry).

Authors:  J Matthew Brennan; Jeptha P Curtis; David Dai; Susan Fitzgerald; Akshay K Khandelwal; John A Spertus; Sunil V Rao; Mandeep Singh; Richard E Shaw; Kalon K L Ho; Ronald J Krone; William S Weintraub; W Douglas Weaver; Eric D Peterson
Journal:  JACC Cardiovasc Interv       Date:  2013-08       Impact factor: 11.195

8.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Borja Ibanez; Stefan James; Stefan Agewall; Manuel J Antunes; Chiara Bucciarelli-Ducci; Héctor Bueno; Alida L P Caforio; Filippo Crea; John A Goudevenos; Sigrun Halvorsen; Gerhard Hindricks; Adnan Kastrati; Mattie J Lenzen; Eva Prescott; Marco Roffi; Marco Valgimigli; Christoph Varenhorst; Pascal Vranckx; Petr Widimský
Journal:  Eur Heart J       Date:  2018-01-07       Impact factor: 29.983

9.  Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry.

Authors:  Javier A Valle; Lisa A Kaltenbach; Steven M Bradley; Robert W Yeh; Sunil V Rao; Hitinder S Gurm; Ehrin J Armstrong; John C Messenger; Stephen W Waldo
Journal:  JACC Cardiovasc Interv       Date:  2017-11-01       Impact factor: 11.195

10.  Reporting trends and outcomes in ST-segment-elevation myocardial infarction national hospital quality assessment programs.

Authors:  James M McCabe; Kevin F Kennedy; Andrew C Eisenhauer; Howard M Waldman; Elizabeth A Mort; Eugene Pomerantsev; Frederic S Resnic; Robert W Yeh
Journal:  Circulation       Date:  2013-11-18       Impact factor: 29.690

View more
  2 in total

1.  Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction.

Authors:  Hyohun Choi; Jang Hoon Lee; Hyuk Kyoon Park; Eunkyu Lee; Myeong Seop Kim; Hyeon Jeong Kim; Bo Eun Park; Hong Nyun Kim; Namkyun Kim; Se Yong Jang; Myung Hwan Bae; Dong Heon Yang; Hun Sik Park; Yongkeun Cho
Journal:  J Korean Med Sci       Date:  2022-05-30       Impact factor: 5.354

2.  Cardiac rupture after ST-elevation myocardial infarction (STEMI): a 'Stitch' in time?

Authors:  Sanjana Nagraj; Behnood Bikdeli; Sahil A Parikh; Saurav Chatterjee
Journal:  J Thorac Dis       Date:  2022-07       Impact factor: 3.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.